(19)
(11) EP 1 309 686 A2

(12)

(88) Date of publication A3:
22.08.2002

(43) Date of publication:
14.05.2003 Bulletin 2003/20

(21) Application number: 01952313.3

(22) Date of filing: 29.06.2001
(51) International Patent Classification (IPC)7C12N 15/12, C12N 15/62, C12N 15/63, C12N 15/11, C12N 1/21, C12N 5/10, G01N 33/68, C12Q 1/68, C07K 14/705, C07K 16/28, A61K 38/17, A61K 39/395, A61K 48/00, A61K 31/7088, A61K 31/713
(86) International application number:
PCT/US0120/751
(87) International publication number:
WO 0200/2602 (10.01.2002 Gazette 2002/02)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 30.06.2000 US 608921

(71) Applicant: Millennium Pharmaceuticals, Inc.
Cambridge,Massachusetts 02139 (US)

(72) Inventor:
  • TSAI, Fong-Ying
    Newton, MA 02168 (US)

(74) Representative: Hall, Robert Leonard et al
Harrison Goddard Foote,Fountain Precinct,Leopold Street
Sheffield S1 2QD
Sheffield S1 2QD (GB)

   


(54) SLGP PROTEIN AND NUCLEIC ACID MOLECULES AND USES THEREFOR